José Ponce

1.6k total citations · 1 hit paper
26 papers, 959 citations indexed

About

José Ponce is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, José Ponce has authored 26 papers receiving a total of 959 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 6 papers in Surgery and 5 papers in Molecular Biology. Recurrent topics in José Ponce's work include Advanced Breast Cancer Therapies (3 papers), HER2/EGFR in Cancer Research (3 papers) and Cancer Genomics and Diagnostics (3 papers). José Ponce is often cited by papers focused on Advanced Breast Cancer Therapies (3 papers), HER2/EGFR in Cancer Research (3 papers) and Cancer Genomics and Diagnostics (3 papers). José Ponce collaborates with scholars based in Spain, Germany and France. José Ponce's co-authors include Gϋnter von Minckwitz, Charles E. Geyer, Priya Rastogi, David Maag, Norman Wolmark, Michael Untch, Sibylle Loibl, W. Fraser Symmans, Xuan Liu and Joyce O’Shaughnessy and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Lancet Oncology.

In The Last Decade

José Ponce

23 papers receiving 935 citations

Hit Papers

Addition of the PARP inhibitor veliparib plus carboplatin... 2018 2026 2020 2023 2018 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial
    2018 516 citations Sibylle Loibl, Joyce O’Shaughnessy et al. The Lancet Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
José Ponce Spain 11 642 298 254 216 176 26 959
Kit Curtius United States 15 238 0.4× 270 0.9× 303 1.2× 251 1.2× 194 1.1× 36 825
Mounir Frikha Tunisia 21 525 0.8× 291 1.0× 524 2.1× 173 0.8× 174 1.0× 80 1.1k
E. Jaeger Germany 16 621 1.0× 105 0.4× 408 1.6× 233 1.1× 463 2.6× 39 1.2k
María José Brito Portugal 16 226 0.4× 175 0.6× 238 0.9× 359 1.7× 222 1.3× 45 790
Elisa Gruppioni Italy 15 216 0.3× 136 0.5× 274 1.1× 159 0.7× 155 0.9× 56 703
Li Zhou China 20 752 1.2× 166 0.6× 515 2.0× 200 0.9× 158 0.9× 111 1.1k
Luı́s Cirnes Portugal 16 309 0.5× 163 0.5× 351 1.4× 194 0.9× 210 1.2× 39 788
Takahiro Einama Japan 17 503 0.8× 134 0.4× 192 0.8× 237 1.1× 297 1.7× 83 890
Stacey Stein United States 18 802 1.2× 327 1.1× 315 1.2× 260 1.2× 387 2.2× 74 1.4k
Antonella Palazzo Italy 17 724 1.1× 349 1.2× 311 1.2× 155 0.7× 495 2.8× 68 1.2k

Countries citing papers authored by José Ponce

Since Specialization
Citations

This map shows the geographic impact of José Ponce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by José Ponce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites José Ponce more than expected).

Fields of papers citing papers by José Ponce

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by José Ponce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by José Ponce. The network helps show where José Ponce may publish in the future.

Co-authorship network of co-authors of José Ponce

This figure shows the co-authorship network connecting the top 25 collaborators of José Ponce. A scholar is included among the top collaborators of José Ponce based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with José Ponce. José Ponce is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ciruelos, Eva, Tomás Pascual, Guillermo Villacampa, et al.. (2024). Primary results from PATRICIA cohort C (SOLTI-1303), a randomized phase II study evaluating palbociclib with trastuzumab and endocrine therapy in pretreated HER2-positive and PAM50 luminal advanced breast cancer.. Journal of Clinical Oncology. 42(16_suppl). 1008–1008. 4 indexed citations
3.
Ortiz-Martínez, Fernando, et al.. (2021). ID1 and ID4 Are Biomarkers of Tumor Aggressiveness and Poor Outcome in Immunophenotypes of Breast Cancer. Cancers. 13(3). 492–492. 12 indexed citations
4.
Loibl, Sibylle, Joyce O’Shaughnessy, Michael Untch, et al.. (2018). Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial. The Lancet Oncology. 19(4). 497–509. 516 indexed citations breakdown →
5.
Escoriza, Juan Carlos Martínez, et al.. (2017). Presence of human papillomavirus DNA in breast cancer: a Spanish case-control study. BMC Cancer. 17(1). 320–320. 41 indexed citations
6.
Martínez-Jáñez, Noelia, Ana De Juan, Luis de la Cruz‐Merino, et al.. (2016). Anti-HER2 Therapy Beyond Second-Line for HER2- Positive Metastatic Breast Cancer: A Short Review and Recommendations for Several Clinical Scenarios from a Spanish Expert Panel. Breast Care. 11(2). 133–138. 2 indexed citations
7.
Peiró, Gloria, Fernando Ortiz-Martínez, Alberto Gallardo, et al.. (2014). Src, a potential target for overcoming trastuzumab resistance in HER2-positive breast carcinoma. British Journal of Cancer. 111(4). 689–695. 72 indexed citations
8.
Ortiz-Martínez, Fernando, Ariadna Perez‐Balaguer, Leire Andrés, et al.. (2013). Association of increased osteopontin and splice variant-c mRNA expression with HER2 and triple-negative/basal-like breast carcinomas subtypes and recurrence. Human Pathology. 45(3). 504–512. 28 indexed citations
9.
Lluch, Aňa, Juan Cueva, Manuel Ruíz‐Borrego, José Ponce, & José Alejandro Pérez Fidalgo. (2013). Zoledronic acid in the treatment of metastatic breast cancer. Anti-Cancer Drugs. 25(1). 1–7. 17 indexed citations
10.
11.
Ponce, José, et al.. (2007). Carcinoma of unknown primary site: development in a single institution of a prognostic model based on clinical and serum variables. Clinical & Translational Oncology. 9(7). 452–458. 19 indexed citations
12.
Ponce, José, et al.. (2007). Primary Meningeal Lymphoma of T-Cell Origin: A Rare Presentation of Primary Central Nervous System Lymphomas. Clinical Lymphoma & Myeloma. 7(8). 546–549. 2 indexed citations
13.
Barbagelata, Alejandro, et al.. (2006). Quiste de vesícula seminal y agenesia renal ipsilateral. Archivos Españoles de Urología. 59(7). 750–750. 1 indexed citations
14.
Beveridge, Roberto Díaz, et al.. (2006). Epidemiological pattern and time trends in testicular germ-cell tumors: a single institution 20-year experience. Clinical & Translational Oncology. 8(8). 588–593. 11 indexed citations
15.
16.
Zotano, Ángel Guerrero, et al.. (2005). Carcinoma microcítico de localización extrapulmonar: ¿es su curso similar a los microcíticos pulmonares?. Clinical & Translational Oncology. 7(2). 55–59. 1 indexed citations
17.
Benlloch, Salvador, et al.. (2001). Pseudoobstrucción colónica crónica secundaria a neurolépticos. Gastroenterología y Hepatología. 24(10). 500–502. 4 indexed citations
18.
Ponce, José, et al.. (1999). La respuesta emocional y posibles correlatos con parámetros biológicos.. 3(2). 1 indexed citations
19.
Ponce, José, et al.. (1996). [The clinical significance of the magnitude of esophageal dilatation in idiopathic achalasia].. PubMed. 19(5). 235–9. 3 indexed citations
20.
Ponce, José, et al.. (1991). [A favorable response to the somatostatin analog SMS 201-995 in a patient with the carcinoid syndrome].. PubMed. 79(3). 215–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kit Curtius Breakdown of academic impact, for papers by Mounir Frikha Breakdown of academic impact, for papers by E. Jaeger Breakdown of academic impact, for papers by María José Brito Breakdown of academic impact, for papers by Elisa Gruppioni Breakdown of academic impact, for papers by Li Zhou Breakdown of academic impact, for papers by Luı́s Cirnes Breakdown of academic impact, for papers by Takahiro Einama Breakdown of academic impact, for papers by Stacey Stein Breakdown of academic impact, for papers by Antonella Palazzo
Rankless by CCL
2026